-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Lipocine Inc (LPCN)
-
-
-
-
-
-
-
Lipocine to Present at H.C. Wainwright 6th Annual NASH Investor Conference
-
-
-
-
-
-
-
Lipocine Inc (LPCN) PT Raised to $3 at H.C. Wainwright Following NDA Resubmission for Tlando Oral TRT
-
-
-
-
-
-
-
Notable Analyst Rating Changes 10/7: (VSLR) (RRC) (DFT) Upgraded; (SEDG) (TSN) (HEES) Downgraded
-
-
22,361 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

